Global Oncology Academy

Expert Perspectives on Treating Relapsed or Refractory Multiple Myeloma

ReachMD Healthcare Image

Which multiple myeloma patients are at risk of replased or refractory disease? Tune in to find out more. 

  • Overview

    The future may be looking bright for patients with multiple myeloma as more therapies emerge. So how can clinicians help to improve patient care? Join Dr. Charles Turck as he dives into this topic with Dr. Morie Gertz, Hematology Specialist at the Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, and Dr. Ravi Vij, Professor of Medicine in the Oncology Division and Section of Bone Marrow Transplantation at the Washington University School of Medicine in St. Louis, Missouri.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free